The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia

Withdrawn before enrolling · Phase 4 · Has a placebo group

Conditions studied: Female Androgenetic Alopecia

In brief

The investigators propose to conduct a head-to-head, randomized clinical trial to compare the effectiveness of Minoxidil with Spironolactone and Finasteride in treating postmenopausal females with Androgenetic Alopecia (AGA).

Key facts

Study ID

NCT02483195

Run by

University of Florida

People needed

0

Starts

2016-08-01

Expected to finish

2018-08-01

Last updated by the study team

2016-09-02

Who can join

Age: 60 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• female
• postmenopausal (>60 years old or with total hysterectomy)
• diagnosed with androgenetic alopecia
• no chemical processing or changes in hair products throughout the study

You may not qualify if…

• men
• premenopausal women (<60 or without hysterectomy)
• participants allergic to any of the study medications (minoxidil, finasteride, spironolactone)
• participants with other co-existing forms of alopecia (traction, alopecia areata, or scarring alopecias)
• participants with obstructive uropathy or advanced liver disease
• prior hair loss treatment within the last 6 months
• hair loss from the chemotherapy or other medication-induced alopecia
• Hair loss for greater than 5 years, as medical therapy is unlikely to have much effect at restoring hair follicles inactive for that long of a period.

Where it is running

• UF Health — Gainesville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.